Actuate Therapeutics Inc. Common stock (ACTU)
Stock · NASDAQ · Health Care
$0.5938as of 10/16/2026
Price chart
Active signals
ACTU Signal Track Record
How signals performed across all stocks →What ACTU's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 15 | -23.0% | 27% | October 7, 2026 |
| Bollinger Band Breakdown | 6 | -12.8% | 33% | June 26, 2026 |
| Bollinger Band Breakout | 6 | -21.4% | 17% | August 21, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -18.7% | 25% | November 28, 2025 |
| Any 20-session window (baseline) | -17.0% | 32% |
Computed by MarketWall from daily closing prices since May 30, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ACTU
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 12
- Website
- actuatetherapeutics.com/
Fundamentals
- 1-day range
- $0.47$0.6399
- Market cap
- $29.43M
- P/E (trailing)
- —
- P/E (forward)
- -0.91
- EPS (trailing)
- $-0.89
- Dividend yield
- —
- Beta
- 1.78
- Avg. volume
- 331.9K
Forecasts
3 analyst ratings
Actuate Therapeutics Inc. Common stock Competitors
Chosen by industry and closest market cap.
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
- GRCEGrace Therapeutics Inc. Common Stock$1.89▼ 3.08%Market cap $28.44MP/E —$1.79$5.18
- RMTIRockwell Medical Inc. Common Stock$7.43▼ 6.89%Market cap $28.26MP/E —$4.89$12.9
- KYNBKyntra Bio Inc. Common Stock$4.85▼ 9.51%Market cap $28.26MP/E 0.12$5.34$11.65
- UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares$3.93▼ 5.30%Market cap $31.35MP/E —$2$17.96
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $1.89 | ▼ 3.08% | $1.79$5.18 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $7.43 | ▼ 6.89% | $4.89$12.9 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.12 | $4.85 | ▼ 9.51% | $5.34$11.65 |
| UPC Universe Pharmaceuticals Inc. Class A Ordinary Shares | $31.35M | — | $3.93 | ▼ 5.30% | $2$17.96 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in CancerYahoo · 10/8/2026
- What's going on in today's sessionChartMill · 10/7/2026
- Wednesday's session: gap up and gap down stocksChartMill · 10/7/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 10/7/2026
- Wondering what's happening in today's pre-market session?ChartMill · 10/7/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 10/7/2026
- Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketBenzinga · 10/7/2026
- Actuate Therapeutics To Sell 50,000,000 Shares At Assumed Price Of $0.819 Per Sharebenzinga · 10/6/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 10/6/2026
Insider Activity
Insider Actions →- SCHMITT DANIEL M · August 14, 2026 · Option Exercise272.1K
- SCHMITT DANIEL M · August 14, 2026 · Tax Withholding120.5K @ $1.01
- Martin H. Huber Jr. · May 21, 2026 · Grant15.0K
- Aaron G.L. Fletcher · May 21, 2026 · Grant15.0K
- RONNEBERG AMY L · May 21, 2026 · Grant15.0K
- THOMSON TODD S · May 21, 2026 · Grant15.0K
- Zabrowski Dan · May 21, 2026 · Grant15.0K
- Sawhney Roger · May 21, 2026 · Grant15.0K
- Keyes Jason A · May 21, 2026 · Grant15.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 13.73M
- Total value held
- $37.62M
- Institutional holders
- 57
- Unknown10.05M
- Unknown1.73M
- Unknown427.2K
- Unknown400.5K
- Unknown228.3K
- Unknown113.3K
- Unknown100.0K
- Unknown97.9K
- Unknown94.6K
- Unknown66.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
ACTU Included in Recent Healthcare Stock Movers
ACTU was listed among 12 healthcare shares that moved in Monday's after‑market session, Friday's intraday session, and Friday's pre‑market session, according to Benzinga reports. The stock is trading near its 10‑touch support level of $1.93 and has a moderate RSI of 39.1, indicating it is not yet overbought or oversold. These sessions show recent interest in the company, but no specific catalyst was highlighted.
ACTU Included in Recent Healthcare Stock Movers. ACTU was listed among 12 healthcare shares that moved in Monday's after‑market session, Friday's intraday session, and Friday's pre‑market session, according to Benzinga reports. The stock is trading near its 10‑touch support level of $1.93 and has a moderate RSI of 39.1, indicating it is not yet overbought or oversold. These sessions show recent interest in the company, but no specific catalyst was highlighted.